Beclometason/Formoterol Stada

Beclometasone/Formoterol Stada is a combination medication used for managing asthma and chronic obstructive pulmonary disease (COPD). This inhaler contains Beclometasone Dipropionate and Formoterol Fumarate Dihydrate, offering both anti-inflammatory and bronchodilator effects.

Beclometasone/Formoterol Stada is primarily used for the maintenance treatment of asthma and COPD. The Beclometasone component helps reduce inflammation in the airways, while Formoterol works as a bronchodilator to relax the muscles around the airways, making it easier to breathe. This combination is often prescribed for long-term management of these respiratory conditions.

Common effects of Beclometasone/Formoterol Stada may include a reduction in asthma symptoms such as wheezing, shortness of breath, and coughing. Some users might experience mild side effects like throat irritation, hoarseness, or a dry mouth. These effects are generally temporary and should be discussed with a healthcare provider if they persist or worsen.

It is important to use Beclometasone/Formoterol Stada as directed by a healthcare professional. Always follow the prescribed dosage and administration instructions. Keep the inhaler clean and store it properly to maintain its effectiveness. If you experience severe side effects or an allergic reaction, seek medical attention immediately.

Beclometasone/Formoterol Stada may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is also advisable to avoid alcohol while using this medication, as it may increase the risk of side effects. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.